Pricing Guide for Dr. Etemad’s Intellxx Panels
Initial Intellxx Testing Package
Intellxx testing, order kit through Intellxx, 15 minute phone consultation, then one hour to review results via telehealth.
Cost: $500 plus cost of testingCan add in person one hour visit within 12 months of consultation for Osteopathic treatment for $400.
This will cover Intellxx testing for any of the following combination packages that involve: Executive ($1200), Resilient Brain ($1300). The Powerhouse ($1700), which includes all three standard panels, requires a 90 minute consultation and costs $750.
Single Standard Panel Package
Intellxx testing, order kit through Intellxx, 15 minute phone consultation, then 45 minute telehealth consultation to review results.
Cost: $400 plus cost of testingCan add in person one hour visit within 12 months of consultation for Osteopathic treatment for $400.
Standard Panels Covered
This will cover Intellxx testing for any of the following panels.
Medical Overview ($700), Brain Optimization ($900), Mental Wellness ($900), Neurodevelopmental panel ($1150).
New Lower Cost Package for New Panel
Intellxx new testing panel, Spotlight on Anxiety and Depression ($450), 15 minute phone consultation plus 30 minute telehealth results review.
Cost: $200Can add in person one hour visit within 12 months of consultation for Osteopathic treatment for $400.
IntellxxDNA vs. Direct-to-Consumer Testing
Genomic data is not the same across different companies, whether direct-to-consumer or direct-to-healthcare-provider.
A lot of people ask why someone would choose Intellxx over a direct-to-consumer genomics test such as 23andMe. IntellxxDNA™ explains that while many genomic companies offer valuable and even fascinating information, each company chooses a different focus and different strengths.
The focus of IntellxxDNA™ is actionable, clinically relevant genetic variants. Specifically, the tool is designed to help improve outcomes, prevent chronic illness, and optimize brain health. Clinical relevance is important, but so is actionability — what can the clinician actually do with the results?
Another key difference is reproducibility. IntellxxDNA™ works with a CLIA/CAP certified lab using a variety of techniques to obtain accurate genotype information. Downloading raw data from direct-to-consumer tests designed primarily for ancestry information and “edutainment” is not appropriate for medical decision making.
Clinically Relevant & Actionable Results
There are important variants, such as Apo E2, that may validate at less than 75% accuracy in certain raw data sources. The 23andMe raw data page includes a warning that its raw data has undergone a general quality review, but only a subset of markers has been individually validated for accuracy. It also notes that the raw data is suitable only for informational use and not for medical, diagnostic, or other use.
Many direct-to-consumer companies look at genes or SNPs independently rather than in combination. This can limit the information that can be provided about a disease state, what the SNPs mean clinically, and what can be done. IntellxxDNA™ reports on panels of interpreted key contributing SNPs and key SNPs that relay benefit, creating a more complete picture for discussion.
- Content: IntellxxDNA™ focuses on actionable, clinically relevant genetic variants.
- Clinical Relevance: Results are designed to support meaningful discussion and potential modifications.
- Reproducibility: Testing is performed through a CLIA/CAP certified lab for accurate genotype information.
- Multifactorial Disease: Chronic disease risk is interpreted through panels rather than isolated SNPs.
- Robust SNP Evaluation: IntellxxDNA™ evaluates broader SNP patterns to support better clinical context.
For patients looking to optimize brain function, improve overall health, and help prevent chronic diseases such as heart disease, diabetes, osteoporosis, and obesity, IntellxxDNA™ provides accurate, clinically relevant, and actionable genomic information.